<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39226091</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2369-2960</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><PubDate><Year>2024</Year><Month>Sep</Month><Day>03</Day></PubDate></JournalIssue><Title>JMIR public health and surveillance</Title><ISOAbbreviation>JMIR Public Health Surveill</ISOAbbreviation></Journal><ArticleTitle>Impact of Long SARS-CoV-2 Omicron Infection on the Health Care Burden: Comparative Case-Control Study Between Omicron and Pre-Omicron Waves.</ArticleTitle><Pagination><StartPage>e53580</StartPage><MedlinePgn>e53580</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e53580</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/53580</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Following the initial acute phase of COVID-19, health care resource use has escalated among individuals with SARS-CoV-2 infection.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aimed to compare new diagnoses of long COVID and the demand for health services in the general population after the Omicron wave with those observed during the pre-Omicron waves, using similar assessment protocols for both periods and to analyze the influence of vaccination.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This matched retrospective case-control study included patients of both sexes diagnosed with acute SARS-CoV-2 infection using reverse transcription polymerase chain reaction or antigen tests in the hospital microbiology laboratory during the pandemic period regardless of whether the patients were hospitalized. We included patients of all ages from 2 health care departments that cover 604,000 subjects. The population was stratified into 2 groups, youths (&lt;18 years) and adults (&#x2265;18 years). Patients were followed-up for 6 months after SARS-CoV-2 infection. Previous vaccination, new diagnoses, and the use of health care resources were recorded. Patients were compared with controls selected using a prospective score matched for age, sex, and the Charlson index.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 41,577 patients with a history of prior COVID-19 infection were included, alongside an equivalent number of controls. This cohort encompassed 33,249 (80%) adults aged &#x2265;18 years and 8328 (20%) youths aged &lt;18 years. Our analysis identified 40 new diagnoses during the observation period. The incidence rate per 100 patients over a 6-month period was 27.2 for vaccinated and 25.1 for unvaccinated adults (P=.09), while among youths, the corresponding rates were 25.7 for vaccinated and 36.7 for unvaccinated individuals (P&lt;.001). Overall, the incidence of new diagnoses was notably higher in patients compared to matched controls. Additionally, vaccinated patients exhibited a reduced incidence of new diagnoses, particularly among women (P&lt;.001) and younger patients (P&lt;.001) irrespective of the number of vaccine doses administered and the duration since the last dose. Furthermore, an increase in the use of health care resources was observed in both adult and youth groups, albeit with lower figures noted in vaccinated individuals. In the comparative analysis between the pre-Omicron and Omicron waves, the incidence of new diagnoses was higher in the former; however, distinct patterns of diagnosis were evident. Specifically, depressed mood (P=.03), anosmia (P=.003), hair loss (P&lt;.001), dyspnea (&lt;0.001), chest pain (P=.04), dysmenorrhea (P&lt;.001), myalgia (P=.011), weakness (P&lt;.001), and tachycardia (P=.015) were more common in the pre-Omicron period. Similarly, health care resource use, encompassing primary care, specialist, and emergency services, was more pronounced in the pre-Omicron wave.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The rise in new diagnoses following SARS-CoV-2 infection warrants attention due to its potential implications for health systems, which may necessitate the allocation of supplementary resources. The absence of vaccination protection presents a challenge to the health care system.</AbstractText><CopyrightInformation>&#xa9;Bernardo Valdivieso-Martinez, Victoria Lopez-Sanchez, Inma Sauri, Javier Diaz, Jose Miguel Calderon, Maria Eugenia Gas-Lopez, Laura Lidon, Juliette Philibert, Jose Luis Lopez-Hontangas, David Navarro, Llanos Cuenca, Maria Jose Forner, Josep Redon. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 03.09.2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Valdivieso-Martinez</LastName><ForeName>Bernardo</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-3344-2369</Identifier><AffiliationInfo><Affiliation>Medical Research Institute, Hospital Universitari i Polit&#xe8;cnic La Fe, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez-Sanchez</LastName><ForeName>Victoria</ForeName><Initials>V</Initials><Identifier Source="ORCID">0009-0006-1303-0622</Identifier><AffiliationInfo><Affiliation>Medical Research Institute, Hospital Universitari i Polit&#xe8;cnic La Fe, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sauri</LastName><ForeName>Inma</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-5017-2618</Identifier><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico de la Comunidad Valenciana (INCLIVA) Research Institute, University of Valencia, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diaz</LastName><ForeName>Javier</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-5822-3325</Identifier><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico de la Comunidad Valenciana (INCLIVA) Research Institute, University of Valencia, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calderon</LastName><ForeName>Jose Miguel</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0003-3280-9114</Identifier><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico de la Comunidad Valenciana (INCLIVA) Research Institute, University of Valencia, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gas-Lopez</LastName><ForeName>Maria Eugenia</ForeName><Initials>ME</Initials><Identifier Source="ORCID">0000-0003-0924-9665</Identifier><AffiliationInfo><Affiliation>Medical Research Institute, Hospital Universitari i Polit&#xe8;cnic La Fe, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lidon</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0009-0001-9441-3193</Identifier><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico de la Comunidad Valenciana (INCLIVA) Research Institute, University of Valencia, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Philibert</LastName><ForeName>Juliette</ForeName><Initials>J</Initials><Identifier Source="ORCID">0009-0009-7592-2935</Identifier><AffiliationInfo><Affiliation>Medical Research Institute, Hospital Universitari i Polit&#xe8;cnic La Fe, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez-Hontangas</LastName><ForeName>Jose Luis</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0003-1426-3672</Identifier><AffiliationInfo><Affiliation>Medical Research Institute, Hospital Universitari i Polit&#xe8;cnic La Fe, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navarro</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-3010-4110</Identifier><AffiliationInfo><Affiliation>Hospital Clinico of Valencia, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuenca</LastName><ForeName>Llanos</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-3589-4182</Identifier><AffiliationInfo><Affiliation>Universitat Polit&#xe8;cnica de Val&#xe8;ncia, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forner</LastName><ForeName>Maria Jose</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-6786-6760</Identifier><AffiliationInfo><Affiliation>Hospital Clinico of Valencia, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Redon</LastName><ForeName>Josep</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-8777-6773</Identifier><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico de la Comunidad Valenciana (INCLIVA) Research Institute, University of Valencia, Valencia, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Public Health Surveill</MedlineTA><NlmUniqueID>101669345</NlmUniqueID><ISSNLinking>2369-2960</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017281" MajorTopicYN="N">Cost of Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Omicron</Keyword><Keyword MajorTopicYN="N">diagnostics</Keyword><Keyword MajorTopicYN="N">emergency department</Keyword><Keyword MajorTopicYN="N">hospitalization</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post&#x2013;COVID-19</Keyword><Keyword MajorTopicYN="N">primary care</Keyword><Keyword MajorTopicYN="N">specialist</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared. The funders played no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>3</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>3</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>3</Day><Hour>11</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39226091</ArticleId><ArticleId IdType="pmc">PMC11408891</ArticleId><ArticleId IdType="doi">10.2196/53580</ArticleId><ArticleId IdType="pii">v10i1e53580</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>GBD 2021 Diseases and Injuries Collaborators  Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024 May 18;403(10440):2133&#x2013;2161. doi: 10.1016/S0140-6736(24)00757-8. 
 
S0140-6736(24)00757-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(24)00757-8</ArticleId><ArticleId IdType="pmc">PMC11122111</ArticleId><ArticleId IdType="pubmed">38642570</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020 Feb 20;382(8):727&#x2013;733. doi: 10.1056/nejmoa2001017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty SE, Guo Y, Heath K, Dasmari&#xf1;as MC, Jubilo KG, Samranvedhya J, Lipsitch M, Cohen K. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2021 May 19;373:n1098. doi: 10.1136/bmj.n1098. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1098</ArticleId><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E, Rushforth A, Wieringa S, Taylor S, Rayner C, Husain L, Greenhalgh T. Persistent symptoms after COVID-19: qualitative study of 114 "long Covid" patients and draft quality principles for services. BMC Health Serv Res. 2020 Dec 20;20(1):1144. doi: 10.1186/s12913-020-06001-y. 
 
10.1186/s12913-020-06001-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-06001-y</ArticleId><ArticleId IdType="doi">10.1186/s12913-020-06001-y</ArticleId><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo P, Cuapio A, Villapol S. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Res Sq. 2021 Mar 01;11(1):16144. doi: 10.21203/rs.3.rs-266574/v1. 
 
rs.3.rs-266574</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-266574/v1</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021 Jun;594(7862):259&#x2013;264. doi: 10.1038/s41586-021-03553-9.10.1038/s41586-021-03553-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosn J, Piroth L, Epaulard O, Le Turnier P, Mentr&#xe9; F, Bachelet D, Laou&#xe9;nan C, French COVID Cohort Study Investigators Groups  Persistent COVID-19 symptoms are highly prevalent 6&#xa0;months after hospitalization: results from a large prospective cohort. Clin Microbiol Infect. 2021 Jul;27(7):1041.e1&#x2013;1041.e4. doi: 10.1016/j.cmi.2021.03.012. 
 
S1198-743X(21)00147-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.03.012</ArticleId><ArticleId IdType="pmc">PMC8107834</ArticleId><ArticleId IdType="pubmed">34125067</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta SD, Talwar A, Lee JT. A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: illness beyond acute infection and public health implications. JAMA. 2020 Dec 08;324(22):2251&#x2013;2252. doi: 10.1001/jama.2020.22717.2773338</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.22717</ArticleId><ArticleId IdType="pubmed">33206133</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, Gibbs KW, Erickson HL, Steingrub JS, Smithline HA, Gong MN, Aboodi MS, Exline MC, Henning DJ, Wilson JG, Khan A, Qadir N, Brown SM, Peltan ID, Rice TW, Hager DN, Ginde AA, Stubblefield WB, Patel MM, Self WH, Feldstein LR, IVY Network Investigators. CDC COVID-19 Response Team Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network - United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020 Jul 31;69(30):993&#x2013;998. doi: 10.15585/mmwr.mm6930e1. doi: 10.15585/mmwr.mm6930e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, Cook JR, Nordvig AS, Shalev D, Sehrawat TS, Ahluwalia N, Bikdeli B, Dietz D, Der-Nigoghossian C, Liyanage-Don N, Rosner GF, Bernstein EJ, Mohan S, Beckley AA, Seres DS, Choueiri TK, Uriel N, Ausiello JC, Accili D, Freedberg DE, Baldwin M, Schwartz A, Brodie D, Garcia CK, Elkind MSV, Connors JM, Bilezikian JP, Landry DW, Wan EY. Post-acute COVID-19 syndrome. Nat Med. 2021 Apr;27(4):601&#x2013;615. doi: 10.1038/s41591-021-01283-z. 
 
10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F, Gemelli Against COVID-19 Post-Acute Care Study Group  Persistent symptoms in patients after acute COVID-19. JAMA. 2020 Aug 11;324(6):603&#x2013;605. doi: 10.1001/jama.2020.12603. 
 
2768351</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Golzardi M, Hromi&#x107;-Jahjefendi&#x107; A, &#x160;utkovi&#x107; J, Aydin O, &#xdc;nal-Ayd&#x131;n P, Be&#x107;irevi&#x107; T, Redwan EM, Rubio-Casillas A, Uversky VN. The aftermath of COVID-19: exploring the long-term effects on organ systems. Biomedicines. 2024 Apr 20;12(4):913. doi: 10.3390/biomedicines12040913. 
 
biomedicines12040913</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines12040913</ArticleId><ArticleId IdType="pmc">PMC11048001</ArticleId><ArticleId IdType="pubmed">38672267</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022 Jun;399(10343):2263&#x2013;2264. doi: 10.1016/s0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise J. Covid-19: long covid risk is lower with omicron than delta, researchers find. BMJ. 2022 Jun 17;377:o1500. doi: 10.1136/bmj.o1500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o1500</ArticleId><ArticleId IdType="pubmed">35714995</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson C. Long covid risk with omicron may be half that of delta. New Scientist. 2022 Jun;254(3392):12. doi: 10.1016/s0262-4079(22)01099-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0262-4079(22)01099-5</ArticleId><ArticleId IdType="pmc">PMC9232251</ArticleId><ArticleId IdType="pubmed">35782298</ArticleId></ArticleIdList></Reference><Reference><Citation>Morioka S, Tsuzuki S, Suzuki M, Terada M, Akashi M, Osanai Y, Kuge C, Sanada M, Tanaka K, Maruki T, Takahashi K, Saito S, Hayakawa K, Teruya K, Hojo M, Ohmagari N. Post COVID-19 condition of the Omicron variant of SARS-CoV-2. J Infect Chemother. 2022 Nov;28(11):1546&#x2013;1551. doi: 10.1016/j.jiac.2022.08.007. 
 
S1341-321X(22)00233-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiac.2022.08.007</ArticleId><ArticleId IdType="pmc">PMC9365517</ArticleId><ArticleId IdType="pubmed">35963600</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao X, Guan Y, Liao Q, Ma Z, Zhang L, Dong J, Lai X, Zheng G, Yang S, Wang C, Liao Z, Song S, Yi H, Lu H. Long-term sequelae of different COVID-19 variants: the original strain versus the Omicron variant. Glob Health Med. 2022 Dec 31;4(6):322&#x2013;326. doi: 10.35772/ghm.2022.01069. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.35772/ghm.2022.01069</ArticleId><ArticleId IdType="pmc">PMC9773225</ArticleId><ArticleId IdType="pubmed">36589219</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhandari S, Rankawat G, Joshi S, Tiwaskar M, Lohmror A, Bhandari S. Post-COVID syndrome: the stranger ghost of culprit COVID-19. J Assoc Physicians India. 2023 Feb 1;71(2):11&#x2013;12. doi: 10.5005/japi-11001-0193.</Citation><ArticleIdList><ArticleId IdType="doi">10.5005/japi-11001-0193</ArticleId><ArticleId IdType="pubmed">37354471</ArticleId></ArticleIdList></Reference><Reference><Citation>Couzin-Frankel J. New long Covid cases decline with Omicron. Science. 2023 Mar 24;379(6638):1174&#x2013;1175. doi: 10.1126/science.adh9054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.adh9054</ArticleId><ArticleId IdType="pubmed">36952419</ArticleId></ArticleIdList></Reference><Reference><Citation>Lokanuwatsatien T, Satdhabudha A, Tangsathapornpong A, Bunjoungmanee P, Sinlapamongkolkul P, Chaiyakulsil C, Sritipsukho P, Tantiyavarong P. Prevalence and associating factors of long COVID in pediatric patients during the Delta and the Omicron variants. Front Pediatr. 2023 May 24;11:1127582. doi: 10.3389/fped.2023.1127582. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2023.1127582</ArticleId><ArticleId IdType="pmc">PMC10244785</ArticleId><ArticleId IdType="pubmed">37292374</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Morello R, Mariani F, De Rose C, Mastrantoni L, Zampino G, Valentini P. Risk of long Covid in children infected with Omicron or pre-Omicron SARS-CoV-2 variants. Acta Paediatr. 2023 Jun 30;112(6):1284&#x2013;1286. doi: 10.1111/apa.16764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.16764</ArticleId><ArticleId IdType="pubmed">36938946</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Zhang L, Zhang Y, Chen G, Wang D, Chen X, Wang Z, Wang J, Che X, Horita N, Seki N. Prevalence and clinical features of long COVID from omicron infection in children and adults. J Infect. 2023 Apr;86(4):e97&#x2013;e99. doi: 10.1016/j.jinf.2023.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2023.02.015</ArticleId><ArticleId IdType="pubmed">36803675</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto Pereira SM, Nugawela MD, Stephenson T, Foret-Bruno P, Dalrymple E, Xu L, Whittaker E, Heyman I, Ford T, Segal T, Chalder T, Ladhani SN, Mensah AA, McOwat K, Simmons R, CLoCk Consortium. Shafran R. Post-Covid-19 condition (long Covid) in children and young people 12 months after infection or reinfection with the Omicron variant: a prospective observational study. Sci Rep. 2024 Apr 30;14(1):9957. doi: 10.1038/s41598-024-60372-4. doi: 10.1038/s41598-024-60372-4.10.1038/s41598-024-60372-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-60372-4</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-60372-4</ArticleId><ArticleId IdType="pmc">PMC11063180</ArticleId><ArticleId IdType="pubmed">38693285</ArticleId></ArticleIdList></Reference><Reference><Citation>Noij L, Blankestijn J, Lap C, van Houten MA, Biesbroek G, Maitland-van der Zee A-H, Abdel-Aziz M, van Goudoever JB, Alsem M, Brackel C, Oostrom K, Hashimoto S, Terheggen-Lagro S. Clinical-based phenotypes in children with pediatric post-COVID-19 condition. World J Pediatr. 2024 Apr 25;:Online ahead of print. doi: 10.1007/s12519-024-00805-2.10.1007/s12519-024-00805-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-024-00805-2</ArticleId><ArticleId IdType="pmc">PMC11269322</ArticleId><ArticleId IdType="pubmed">38664324</ArticleId></ArticleIdList></Reference><Reference><Citation>Du M, Ma Y, Deng J, Liu M, Liu J. Comparison of long COVID-19 caused by different SARS-CoV-2 strains: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022 Nov 30;19(23):16010. doi: 10.3390/ijerph192316010. 
 
ijerph192316010</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192316010</ArticleId><ArticleId IdType="pmc">PMC9736973</ArticleId><ArticleId IdType="pubmed">36498103</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez J, Dehesa-Canseco F, V&#xe1;zquez-L&#xf3;pez AB, Res&#xe9;ndiz-Sandoval M, Caire-Juvera G, Sol&#xed;s-Hern&#xe1;ndez M, Valenzuela O, G&#xf3;mez-Gil B, Mata-Haro V. Neutralization of Omicron BA.1, BA.5.1.6, BQ.1.3 and XBB1.1 induced by heterologous vaccination Ad5-nCoV and mRNA-1273. Signal Transduct Target Ther. 2023 Apr 29;8(1):174. doi: 10.1038/s41392-023-01447-y. doi: 10.1038/s41392-023-01447-y.10.1038/s41392-023-01447-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01447-y</ArticleId><ArticleId IdType="doi">10.1038/s41392-023-01447-y</ArticleId><ArticleId IdType="pmc">PMC10147998</ArticleId><ArticleId IdType="pubmed">37120638</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo J, Zhang J, Tang HT, Wong HK, Lyu A, Cheung CH, Bian Z. Prevalence and risk factors of long COVID 6-12 months after infection with the Omicron variant among nonhospitalized patients in Hong Kong. J Med Virol. 2023 Jun 19;95(6):e28862. doi: 10.1002/jmv.28862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28862</ArticleId><ArticleId IdType="pubmed">37334978</ArticleId></ArticleIdList></Reference><Reference><Citation>AlBahrani S, AlBarrak A, AlGubaisi N, Alkurdi H, Alburaiki D, AlGhamdi A, AlOthaiqy M, Tayeb S, Tayeb N, Abdraboh S, Khairi A, Alshareef L, AlHarbi A, AlRabeeah S, Alqahtani AS, Alqahtani JS, Hakami FH, Al-Maqati TN, Alkhrashi SA, Almershad MM, AlAbbadi A, Hakami MH, Faqihi O, Altawfiq KJA, Jebakumar AZ, Al-Tawfiq JA. Self-reported long COVID-19 symptoms are rare among vaccinated healthcare workers. J Infect Public Health. 2023 Aug;16(8):1276&#x2013;1280. doi: 10.1016/j.jiph.2023.05.037. 
 
S1876-0341(23)00201-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2023.05.037</ArticleId><ArticleId IdType="pmc">PMC10240906</ArticleId><ArticleId IdType="pubmed">37315430</ArticleId></ArticleIdList></Reference><Reference><Citation>Brannock MD, Chew RF, Preiss AJ, Hadley EC, Redfield S, McMurry JA, Leese PJ, Girvin AT, Crosskey M, Zhou AG, Moffitt RA, Funk MJ, Pfaff ER, Haendel MA, Chute CG, N3C. RECOVER Consortia Long COVID risk and pre-COVID vaccination in an EHR-based cohort study from the RECOVER program. Nat Commun. 2023 May 22;14(1):2914. doi: 10.1038/s41467-023-38388-7. doi: 10.1038/s41467-023-38388-7.10.1038/s41467-023-38388-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-38388-7</ArticleId><ArticleId IdType="doi">10.1038/s41467-023-38388-7</ArticleId><ArticleId IdType="pmc">PMC10201472</ArticleId><ArticleId IdType="pubmed">37217471</ArticleId></ArticleIdList></Reference><Reference><Citation>General Data Protection Regulation: GDPR. General Data Protection Regulation.  [2024-07-23].  
 https://gdpr-info.eu/
</Citation></Reference><Reference><Citation>Valdivieso-Mart&#xed;nez B, Sauri I, Philibert J, Calderon J, Gas M, Diaz J, L&#xf3;pez-Hontangas J, Navarro D, Forner M, Redon J. Impact of long-COVID on health care burden: a case-control study. JCM. 2023 Sep 05;12(18):5768. doi: 10.3390/jcm12185768. doi: 10.3390/jcm12185768.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12185768</ArticleId><ArticleId IdType="doi">10.3390/jcm12185768</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedberg P, Naucl&#xe9;r P. Post-COVID-19 condition after SARS-CoV-2 infections during the Omicron surge vs the Delta, Alpha, and wild type periods in Stockholm, Sweden. J Infect Dis. 2024 Jan 12;229(1):133&#x2013;136. doi: 10.1093/infdis/jiad382. 
 
7259851</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiad382</ArticleId><ArticleId IdType="pmc">PMC10786247</ArticleId><ArticleId IdType="pubmed">37665981</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnusson K, Kristoffersen DT, Dell'Isola A, Kiadaliri A, Turkiewicz A, Runhaar J, Bierma-Zeinstra S, Englund M, Magnus PM, Kinge JM. Post-COVID medical complaints following infection with SARS-CoV-2 Omicron vs Delta variants. Nat Commun. 2022 Nov 30;13(1):7363. doi: 10.1038/s41467-022-35240-2. doi: 10.1038/s41467-022-35240-2.10.1038/s41467-022-35240-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-35240-2</ArticleId><ArticleId IdType="doi">10.1038/s41467-022-35240-2</ArticleId><ArticleId IdType="pmc">PMC9709355</ArticleId><ArticleId IdType="pubmed">36450749</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedberg P, Granath F, Bruchfeld J, Askling J, Sj&#xf6;holm D, Fored M, F&#xe4;rnert A, Naucler P. Post COVID-19 condition diagnosis: a population-based cohort study of occurrence, associated factors, and healthcare use by severity of acute infection. J Intern Med. 2023 Feb 07;293(2):246&#x2013;258. doi: 10.1111/joim.13584. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13584</ArticleId><ArticleId IdType="pmc">PMC9877994</ArticleId><ArticleId IdType="pubmed">36478477</ArticleId></ArticleIdList></Reference><Reference><Citation>Diexer S, Klee B, Gottschick C, Xu C, Broda A, Purschke O, Binder M, Frese T, Girndt M, Hoell JI, Moor I, Gekle M, Mikolajczyk R. Association between virus variants, vaccination, previous infections, and post-COVID-19 risk. Int J Infect Dis. 2023 Nov;136:14&#x2013;21. doi: 10.1016/j.ijid.2023.08.019. 
 
S1201-9712(23)00702-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2023.08.019</ArticleId><ArticleId IdType="pubmed">37634619</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammel IS, Tosi DM, Tang F, Pott H, Ruiz JG. Frailty as a risk factor for post-acute sequelae of COVID-19 among US veterans during the Delta and Omicron waves. J Am Geriatr Soc. 2023 Dec 19;71(12):3826&#x2013;3835. doi: 10.1111/jgs.18584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.18584</ArticleId><ArticleId IdType="pubmed">37725480</ArticleId></ArticleIdList></Reference><Reference><Citation>Izquierdo-Pujol J, Moron-Lopez S, Dalmau J, Gonzalez-Aumatell A, Carreras-Abad C, Mendez M, Rodrigo C, Martinez-Picado J. Post COVID-19 condition in children and youths: an emerging problem. Front Pediatr. 2022 May 11;10:894204. doi: 10.3389/fped.2022.894204. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.894204</ArticleId><ArticleId IdType="pmc">PMC9130634</ArticleId><ArticleId IdType="pubmed">35633949</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren-Gash C, Lacey A, Cook S, Stocker D, Toon S, Lelii F, Ford B, Ireland G, Ladhani SN, Stephenson T, Nguipdop-Djomo P, Mangtani P, COVID-19 Schools Infection Survey 2 Study Group  Post-COVID-19 condition and persisting symptoms in English schoolchildren: repeated surveys to March 2022. BMC Infect Dis. 2023 Apr 05;23(1):201. doi: 10.1186/s12879-023-08203-1. 
 
10.1186/s12879-023-08203-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08203-1</ArticleId><ArticleId IdType="doi">10.1186/s12879-023-08203-1</ArticleId><ArticleId IdType="pmc">PMC10075149</ArticleId><ArticleId IdType="pubmed">37020190</ArticleId></ArticleIdList></Reference><Reference><Citation>Yildirim Arslan S, Avcu G, Sahbudak Bal Z, Arslan A, Ozkinay FF, Kurugol Z. Evaluation of post-COVID symptoms of the SARS-CoV-2 Delta and Omicron variants in children: a prospective study. Eur J Pediatr. 2023 Oct 01;182(10):4565&#x2013;4571. doi: 10.1007/s00431-023-05134-6.10.1007/s00431-023-05134-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-023-05134-6</ArticleId><ArticleId IdType="pubmed">37526704</ArticleId></ArticleIdList></Reference><Reference><Citation>Leahy J, Bajracharya R, Altonen B, Ferreira-Ortiz M, Silvera L, Astua A. Post-discharge healthcare usage and costs from March 2020 through the Omicron surge for individuals hospitalized with COVID-19. Cureus. 2023 Dec;15(12):e50663. doi: 10.7759/cureus.50663. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.50663</ArticleId><ArticleId IdType="pmc">PMC10790598</ArticleId><ArticleId IdType="pubmed">38229792</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Piazza M, Boner AL, Bellanti JA. Long COVID: a proposed hypothesis-driven model of viral persistence for the pathophysiology of the syndrome. Allergy Asthma Proc. 2022 May 01;43(3):187&#x2013;193. doi: 10.2500/aap.2022.43.220018. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.2500/aap.2022.43.220018</ArticleId><ArticleId IdType="pmc">PMC9106095</ArticleId><ArticleId IdType="pubmed">35524358</ArticleId></ArticleIdList></Reference><Reference><Citation>L'Huillier AG, Pagano S, Baggio S, Meyer B, Andrey DO, Nehme M, Guessous I, Eberhardt CS, Huttner A, Posfay-Barbe KM, Yerly S, Siegrist C, Kaiser L, Vuilleumier N. Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistence. Eur J Clin Invest. 2022 Oct 02;52(10):e13818. doi: 10.1111/eci.13818. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13818</ArticleId><ArticleId IdType="pmc">PMC9348059</ArticleId><ArticleId IdType="pubmed">35598178</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>